Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Sunshine Biopharma (SBFM) Depreciation & Amortization - Total (2019 - 2025)

Sunshine Biopharma filings provide 7 years of Depreciation & Amortization - Total readings, the most recent being -$56801.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization - Total fell 389.79% to -$56801.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $176346.0, a 20.36% increase, with the full-year FY2025 number at $176346.0, up 20.36% from a year prior.
  • Depreciation & Amortization - Total hit -$56801.0 in Q4 2025 for Sunshine Biopharma, down from $95821.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $95821.0 in Q3 2025 to a low of -$56801.0 in Q4 2025.
  • Median Depreciation & Amortization - Total over the past 5 years was $3904.0 (2023), compared with a mean of $22749.3.
  • Biggest five-year swings in Depreciation & Amortization - Total: skyrocketed 4616.1% in 2023 and later crashed 397.05% in 2024.
  • Sunshine Biopharma's Depreciation & Amortization - Total stood at $3184.0 in 2021, then skyrocketed by 353.99% to $14455.0 in 2022, then plummeted by 72.99% to $3904.0 in 2023, then crashed by 397.05% to -$11597.0 in 2024, then plummeted by 389.79% to -$56801.0 in 2025.
  • The last three reported values for Depreciation & Amortization - Total were -$56801.0 (Q4 2025), $95821.0 (Q3 2025), and $72533.0 (Q2 2025) per Business Quant data.